Daan van Well filed an initial statement of beneficial ownership as Chief Legal Officer of Sophia Genetics. The filing reported direct beneficial ownership of 261,922 ordinary shares. It also reported share options for 671,263 ordinary shares, with exercise prices ranging from USD 3.29 to USD 18.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001840706-26-000051), on March 18, 2026, and is solely responsible for the information contained therein.
Comments